Kidney Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Jul-2017
  • Tables : 236
  • Figures : 78
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT56MR
  • Format : ppt

Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes. This cancer originates in two principal locations of the kidney – the renal pelvis and the renal tubule.

A new report published by Fact.MR estimates the global kidney cancer diagnostics market to exhibit an impressive expansion at during the forecast period 2017 to 2022. In terms of revenues, the global market for kidney cancer diagnostics will reach nearly US$ 700 Mn by 2022-end.

Targeted Systemic Therapies for Metastatic Kidney Cancer are Providing Significant Benefits to Survival and Progression

Over the past few years, the diagnosis and management of kidney cancer, or, renal cell carcinoma (RCC), have undergone tremendous transformations. A number of discoveries, studies, and trails are being taken in renal mass biopsy, minimally-invasive thermal ablation, and active surveillance, owing to the surge in diagnosis rate of small renal masses, usually in patients with high morbidity risks related to operative treatment. In addition, targeted systemic therapies associated with metastatic kidney cancer have replaced cytokine-based treatment, providing significant benefits to survival and progression. Recent trails and reviews have cemented the partial nephrectomy’s role as the standard diagnosis-based surgical management option for majority of low-stage masses, and roles of adrenalectomy and lymphadenectomy pertaining to nephrectomy. These incidences are estimated to augment growth of the global kidney cancer diagnostics market.

Kidney cancer has been witnessed to occur majorly in older population. Diagnosis of kidney cancer becomes an intricate task, considering the condition of geriatric patients. While staple diagnostic technologies such as MRI and CT scan continue to play a pivotal role in the global market, patients are also expecting the emergence of all-inclusive diagnosis tests. Medical organizations are also funneling high investments in R&D of kidney cancer diagnostics, particularly to improve the precision of early stage diagnosis tests. Through advancements in medical technology, the global market for kidney cancer diagnostics is also expected to witness emergence of new tests that can simultaneously decelerate the pace of tumor maturation between multiple stages of kidney cancer.

Market Taxonomy

Test Type

End User

Indication

Immunohistochemistry

Hospital Associated Labs

Renal Cell Carcinoma

Urine Analysis

Independent Diagnostic Laboratories

Transitional Cell Carcinoma

Complete Blood Count

Cancer Research Institutes

Wilms Tumor

Blood Chemistry Test

Others

Kidney Lymphoma

   

Kidney Sarcoma

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Hospital-associated Labs will Remain Preferred for Kidney Cancer Diagnostics

On the basis of end-users, hospital-associated labs are estimated to remain preferred for kidney cancer diagnostics, accounting for the largest revenues by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global kidney cancer diagnostics market. In addition, cancer research institutes are expected to register the highest CAGR in the market through 2022.

Immunochemistry tests will continue to be sought-after for kidney cancer diagnostics, with revenues expected to reach US$ 351.8 Mn by 2022-end. This test type segment is projected to register the highest CAGR in the market through 2022, followed by complete blood count test.

Urine analysis will remain the second largest adopted tests for kidney cancer diagnostics across the globe. However, revenues from blood chemistry tests of kidney cancer diagnostics will continue to be lower as compared to rest of the test segments in the market.

North America to Remain the Largest Market for Kidney Cancer Diagnostics

In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.

Competition Tracking

Myriad Genetics Inc, NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories are observed as key players in the global market for kidney cancer diagnostics.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1 Global Kidney Cancer Diagnostics Market - Executive Summary 13

Chapter 2 Global Kidney Cancer Diagnostics Market Overview 15
2.1 Introduction 15
      2.1.1 Global Kidney Cancer Diagnostics Market Taxonomy 15
      2.1.2 Global Kidney Cancer Diagnostics Market Definition 15
2.2 Global Kidney Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 16
      2.2.1 Global Kidney Cancer Diagnostics Market Y-o-Y Growth 16
2.3 Global Kidney Cancer Diagnostics Market Dynamics 16
      2.3.1 Drivers 16
      2.3.2 Restraints 17
      2.3.3 Trends 17
2.4 Supply Chain 17
2.5 Epidemiology 17
2.6 List of Distributors 17
2.7 Average Pricing Analysis 18
2.8 Regulations 18
2.9 Key Participants Market Presence (Intensity Map) By Region 18

Chapter 3 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Test Type 19
3.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 19
      3.1.1 Immunohistochemistry Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 19
              3.1.1.1 Revenue (US$ Mn) Comparison, By Region 19
              3.1.1.2 Market Share Comparison, By Region 21
              3.1.1.3 Y-o-Y growth Comparison, By Region 21
      3.1.2 Urine Analysis Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 22
              3.1.2.1 Revenue (US$ Mn) Comparison, By Region 22
              3.1.2.2 Market Share Comparison, By Region 24
              3.1.2.3 Y-o-Y growth Comparison, By Region 24
      3.1.3 Complete Blood Count Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 25
              3.1.3.1 Revenue (US$ Mn) Comparison, By Region 25
              3.1.3.2 Market Share Comparison, By Region 27
              3.1.3.3 Y-o-Y growth Comparison, By Region 27
3.1.4 Blood Chemistry Test Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 28
              3.1.4.1 Revenue (US$ Mn) Comparison, By Region 28
              3.1.4.2 Market Share Comparison, By Region 30
              3.1.4.3 Y-o-Y growth Comparison, By Region 30

Chapter 4 Global Kidney Cancer Diagnostics Market Analysis and Forecast By End User 32
4.1 Global Kidney Cancer Diagnostics Market Size and Forecast By End User, 2012-2022 32
      4.1.1 Hospital Associated Labs Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 32
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region 32
              4.1.1.2 Market Share Comparison, By Region 34
              4.1.1.3 Y-o-Y growth Comparison, By Region 34
      4.1.2 Independent Diagnostic Laboratories Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 35
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region 35
              4.1.2.2 Market Share Comparison, By Region 37
              4.1.2.3 Y-o-Y growth Comparison, By Region 37
      4.1.3 Cancer Research Institutes Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 38
              4.1.3.1 Revenue (US$ Mn) Comparison, By Region 38
              4.1.3.2 Market Share Comparison, By Region 40
              4.1.3.3 Y-o-Y growth Comparison, By Region 40
    4.1.4 Others Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 41
              4.1.4.1 Revenue (US$ Mn) Comparison, By Region 41
              4.1.4.2 Market Share Comparison, By Region 43
              4.1.4.3 Y-o-Y growth Comparison, By Region 43

Chapter 5 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Indication 45
5.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Indication, 2012-2022 45
      5.1.1 Renal Cell Carcinoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 45
              5.1.1.1 Revenue (US$ Mn) Comparison, By Region 45
              5.1.1.2 Market Share Comparison, By Region 47
              5.1.1.3 Y-o-Y growth Comparison, By Region 47
      5.1.2 Transitional Cell Carcinoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 48
              5.1.2.1 Revenue (US$ Mn) Comparison, By Region 48
              5.1.2.2 Market Share Comparison, By Region 50
              5.1.2.3 Y-o-Y growth Comparison, By Region 50
      5.1.3 Wilms Tumor Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 51
              5.1.3.1 Revenue (US$ Mn) Comparison, By Region 51
              5.1.3.2 Market Share Comparison, By Region 53
              5.1.3.3 Y-o-Y growth Comparison, By Region 53
      5.1.4 Kidney Lymphoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 54
              5.1.4.1 Revenue (US$ Mn) Comparison, By Region 54
              5.1.4.2 Market Share Comparison, By Region 56
              5.1.4.3 Y-o-Y growth Comparison, By Region 56
      5.1.5 Kidney Sarcoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 57
              5.1.5.1 Revenue (US$ Mn) Comparison, By Region 57
              5.1.5.2 Market Share Comparison, By Region 59
              5.1.5.3 Y-o-Y growth Comparison, By Region 59

Chapter 6 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Region 61
6.1 Global Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 61
      6.1.1 North America Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 61
              6.1.1.1 Revenue (US$ Mn) Comparison, By Test Type 61
              6.1.1.2 Revenue (US$ Mn) Comparison, By End User 63
              6.1.1.3 Revenue (US$ Mn) Comparison, By Indication 65
      6.1.2 Latin America Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 67
              6.1.2.1 Revenue (US$ Mn) Comparison, By Test Type 67
              6.1.2.2 Revenue (US$ Mn) Comparison, By End User 69
              6.1.2.3 Revenue (US$ Mn) Comparison, By Indication 71
      6.1.3 Europe Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 73
              6.1.3.1 Revenue (US$ Mn) Comparison, By Test Type 73
              6.1.3.2 Revenue (US$ Mn) Comparison, By End User 74
              6.1.3.3 Revenue (US$ Mn) Comparison, By Indication 76
      6.1.4 Japan Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 78
              6.1.4.1 Revenue (US$ Mn) Comparison, By Test Type 78
              6.1.4.2 Revenue (US$ Mn) Comparison, By End User 80
              6.1.4.3 Revenue (US$ Mn) Comparison, By Indication 81
      6.1.5 APEJ Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 83
              6.1.5.1 Revenue (US$ Mn) Comparison, By Test Type 83
              6.1.5.2 Revenue (US$ Mn) Comparison, By End User 85
              6.1.5.3 Revenue (US$ Mn) Comparison, By Indication 87
      6.1.6 MEA Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 89
              6.1.6.1 Revenue (US$ Mn) Comparison, By Test Type 89
              6.1.6.2 Revenue (US$ Mn) Comparison, By End User 91
              6.1.6.3 Revenue (US$ Mn) Comparison, By Indication 92

Chapter 7 North America Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 95
7.1 US Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 95
      7.1.1 Revenue (US$ Mn) Comparison, By Test Type 95
      7.1.2 Revenue (US$ Mn) Comparison, By End User 96
      7.1.3 Revenue (US$ Mn) Comparison, By Indication 97
7.2 Canada Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 98
      7.2.1 Revenue (US$ Mn) Comparison, By Test Type 98
      7.2.2 Revenue (US$ Mn) Comparison, By End User 99
      7.2.3 Revenue (US$ Mn) Comparison, By Indication 100

Chapter 8 Latin America Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 101
8.1 Brazil Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 101
      8.1.1 Revenue (US$ Mn) Comparison, By Test Type 101
      8.1.2 Revenue (US$ Mn) Comparison, By End User 102
8.1.3 Revenue (US$ Mn) Comparison, By Indication 103
8.2 Mexico Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 104
      8.2.1 Revenue (US$ Mn) Comparison, By Test Type 104
      8.2.2 Revenue (US$ Mn) Comparison, By End User 105
      8.2.3 Revenue (US$ Mn) Comparison, By Indication 106
8.3 Argentina Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 107
      8.3.1 Revenue (US$ Mn) Comparison, By Test Type 107
      8.3.2 Revenue (US$ Mn) Comparison, By End User 108
8.3.3 Revenue (US$ Mn) Comparison, By Indication 109

Chapter 9 Europe Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 110
9.1 Germany Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 110
      9.1.1 Revenue (US$ Mn) Comparison, By Test Type 110
      9.1.2 Revenue (US$ Mn) Comparison, By End User 111
      9.1.3 Revenue (US$ Mn) Comparison, By Indication 112
9.2 UK Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 113
      9.2.1 Revenue (US$ Mn) Comparison, By Test Type 113
      9.2.2 Revenue (US$ Mn) Comparison, By End User 114
      9.2.3 Revenue (US$ Mn) Comparison, By Indication 115
9.3 France Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 116
      9.3.1 Revenue (US$ Mn) Comparison, By Test Type 116
      9.3.2 Revenue (US$ Mn) Comparison, By End User 117
      9.3.3 Revenue (US$ Mn) Comparison, By Indication 118
9.4 Spain Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 119
      9.4.1 Revenue (US$ Mn) Comparison, By Test Type 119
      9.4.2 Revenue (US$ Mn) Comparison, By End User 120
      9.4.3 Revenue (US$ Mn) Comparison, By Indication 121
9.5 Italy Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 122
      9.5.1 Revenue (US$ Mn) Comparison, By Test Type 122
      9.5.2 Revenue (US$ Mn) Comparison, By End User 123
9.5.3 Revenue (US$ Mn) Comparison, By Indication 124
9.6 Nordic Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 125
      9.6.1 Revenue (US$ Mn) Comparison, By Test Type 125
      9.6.2 Revenue (US$ Mn) Comparison, By End User 126
      9.6.3 Revenue (US$ Mn) Comparison, By Indication 127

Chapter 10 Japan Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 128
10.1 Japan  Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 128
       10.1.1 Revenue (US$ Mn) Comparison, By Test Type 128
       10.1.2 Revenue (US$ Mn) Comparison, By End User 129
       10.1.3 Revenue (US$ Mn) Comparison, By Indication 130

Chapter 11 APEJ Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 131
11.1 China Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 131
        11.1.1 Revenue (US$ Mn) Comparison, By Test Type 131
        11.1.2 Revenue (US$ Mn) Comparison, By End User 132
        11.1.3 Revenue (US$ Mn) Comparison, By Indication 133
11.2 India Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 134
        11.2.1 Revenue (US$ Mn) Comparison, By Test Type 134
11.2.2 Revenue (US$ Mn) Comparison, By End User 135
        11.2.3 Revenue (US$ Mn) Comparison, By Indication 136
11.3 Malaysia Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 137
        11.3.1 Revenue (US$ Mn) Comparison, By Test Type 137
        11.3.2 Revenue (US$ Mn) Comparison, By End User 138
        11.3.3 Revenue (US$ Mn) Comparison, By Indication 139
11.4 Thailand Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 140
        11.4.1 Revenue (US$ Mn) Comparison, By Test Type 140
        11.4.2 Revenue (US$ Mn) Comparison, By End User 141
        11.4.3 Revenue (US$ Mn) Comparison, By Indication 142
11.5 Singapore Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 143
        11.5.1 Revenue (US$ Mn) Comparison, By Test Type 143
        11.5.2 Revenue (US$ Mn) Comparison, By End User 144
        11.5.3 Revenue (US$ Mn) Comparison, By Indication 145
11.6 Australia Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 146
        11.6.1 Revenue (US$ Mn) Comparison, By Test Type 146
        11.6.2 Revenue (US$ Mn) Comparison, By End User 147
        11.6.3 Revenue (US$ Mn) Comparison, By Indication 148

Chapter 12 MEA Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 149
12.1 GCC Countries Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 149
       12.1.1 Revenue (US$ Mn) Comparison, By Test Type 149
       12.1.2 Revenue (US$ Mn) Comparison, By End User 150
       12.1.3 Revenue (US$ Mn) Comparison, By Indication 151
12.2 South Africa Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 152
       12.2.1 Revenue (US$ Mn) Comparison, By Test Type 152
       12.2.2 Revenue (US$ Mn) Comparison, By End User 153
       12.2.3 Revenue (US$ Mn) Comparison, By Indication 154
12.3 Nigeria Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 155
       12.3.1 Revenue (US$ Mn) Comparison, By Test Type 155
       12.3.2 Revenue (US$ Mn) Comparison, By End User 156
       12.3.3 Revenue (US$ Mn) Comparison, By Indication 157
12.4 Israel Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 158
       12.4.1 Revenue (US$ Mn) Comparison, By Test Type 158
       12.4.2 Revenue (US$ Mn) Comparison, By End User 159
       12.4.3 Revenue (US$ Mn) Comparison, By Indication 160

Chapter 13 Company Profile 161
13.1 Abbott Laboratories 161
       13.1.1 Company Overview 161
       13.1.2 Product Overview 162
       13.1.3 Key Financials 162
       13.1.4 Key Developments 162
13.2 Thermo Fisher Scientific Inc. 163
       13.2.1 Company Overview 163
       13.2.2 Product Overview 163
       13.2.3 Key Financials 164
       13.2.4 SWOT Analysis 164
       13.2.5 Key Developments 165
13.3 Rosetta Genomics 166
       13.3.1 Company Overview 166
       13.3.2 Product Overview 166
       13.3.3 Key Financials 166
13.4 Sysmex Corporation 167
       13.4.1 Company Overview 167
       13.4.2 Product Overview 167
       13.4.3 Key Financials 167
    13.4.4 Key Developments 168
    13.4.5 SWOT Analysis 168
13.5 Roche Holding AG. 169
    13.5.1 Company Overview 169
    13.5.2 Product Overview 169
    13.5.3 Key Financials 170
    13.5.4 Key Developments 170
    13.5.5 SWOT Analysis 171
13.6 NanoString Technologies Inc 174
    13.6.1 Company Overview 174
    13.6.2 Product Overview 174
    13.6.3 Key Financials 175
13.7 NeoGenomics Laboratories, Inc. 176
    13.7.1 Company Overview 176
    13.7.2 Key Financials 176
13.8 Quest Diagnostics Incorporated 177
    13.8.1 Company Overview 177
    13.8.2 Product Overview 177
    13.8.3 Key Financials 177
    13.8.4 SWOT Analysis 178
13.9 Illumina, Inc. 181
    13.9.1 Company Overview 181
    13.9.2 Product Overview 182
    13.9.3 Key Financials 182
    13.9.4 Key Developments 182
13.9.5 SWOT Analysis 183
13.10 Myriad Genetics Inc 184
    13.10.1 Company Overview 184
    13.10.2 Product Overview 184
    13.10.3 Key Financials 185
    13.10.4 SWOT Analysis 185

Chapter 14 Disclaimer and Contact information 189

TABLE 1 Global Kidney Cancer Diagnostics Market Value (US$ Mn), 2012-2016 30
TABLE 2 Global Kidney Cancer Diagnostics Market Value (US$ Mn), 2017-2022 31
TABLE 3 Global Kidney Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 33
TABLE 4 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2012-2016 36
TABLE 5 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2017-2022 37
TABLE 6 Global Immunohistochemistry Segment Market Share, By Region 2012-2016 38
TABLE 7 Global Immunohistochemistry Segment Market Share, By Region 2017-2022 38
TABLE 8 Global Immunohistochemistry Segment Y-o-Y, By Region 2015-2022 38
TABLE 9 Global Urine Analysis Segment Value (US$ Mn), By Region 2012-2016 39
TABLE 10 Global Urine Analysis Segment Value (US$ Mn), By Region 2017-2022 40
TABLE 11 Global Urine Analysis Segment Market Share, By Region 2012-2016 41
TABLE 12 Global Urine Analysis Segment Market Share, By Region 2017-2022 41
TABLE 13 Global Urine Analysis Segment Y-o-Y, By Region 2015-2022 41
TABLE 14 Global Complete Blood Count Segment Value (US$ Mn), By Region 2012-2016 42
TABLE 15 Global Complete Blood Count Segment Value (US$ Mn), By Region 2017-2022 43
TABLE 16 Global Complete Blood Count Segment Market Share, By Region 2012-2016 44
TABLE 17 Global Complete Blood Count Segment Market Share, By Region 2017-2022 44
TABLE 18 Global Complete Blood Count Segment Y-o-Y, By Region 2015-2022 44
TABLE 19 Global Blood Chemistry Test Segment Value (US$ Mn), By Region 2012-2016 45
TABLE 20 Global Blood Chemistry Test Segment Value (US$ Mn), By Region 2017-2022 46
TABLE 21 Global Blood Chemistry Test Segment Market Share, By Region 2012-2016 47
TABLE 22 Global Blood Chemistry Test Segment Market Share, By Region 2017-2022 47
TABLE 23 Global Blood Chemistry Test Segment Y-o-Y, By Region 2015-2022 47
TABLE 24 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2012-2016 49
TABLE 25 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2022 50
TABLE 26 Global Hospital Associated Labs Segment Market Share, By Region 2012-2016 51
TABLE 27 Global Hospital Associated Labs Segment Market Share, By Region 2017-2022 51
TABLE 28 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2022 51
TABLE 29 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2012-2016 52
TABLE 30 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2022 53
TABLE 31 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2012-2016 54
TABLE 32 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2022 54
TABLE 33 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2022 54
TABLE 34 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2012-2016 55
TABLE 35 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2022 56
TABLE 36 Global Cancer Research Institutes Segment Market Share, By Region 2012-2016 57
TABLE 37 Global Cancer Research Institutes Segment Market Share, By Region 2017-2022 57
TABLE 38 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2022 57
TABLE 39 Global Others Segment Value (US$ Mn), By Region 2012-2016 58
TABLE 40 Global Others Segment Value (US$ Mn), By Region 2017-2022 59
TABLE 41 Global Others Segment Market Share, By Region 2012-2016 60
TABLE 42 Global Others Segment Market Share, By Region 2017-2022 60
TABLE 43 Global Others Segment Y-o-Y, By Region 2015-2022 60
TABLE 44 Global Renal Cell Carcinoma Segment Value (US$ Mn), By Region 2012-2016 62
TABLE 45 Global Renal Cell Carcinoma Segment Value (US$ Mn), By Region 2017-2022 63
TABLE 46 Global Renal Cell Carcinoma Segment Market Share, By Region 2012-2016 64
TABLE 47 Global Renal Cell Carcinoma Segment Market Share, By Region 2017-2022 64
TABLE 48 Global Renal Cell Carcinoma Segment Y-o-Y, By Region 2015-2022 64
TABLE 49 Global Transitional Cell Carcinoma Segment Value (US$ Mn), By Region 2012-2016 65
TABLE 50 Global Transitional Cell Carcinoma Segment Value (US$ Mn), By Region 2017-2022 66
TABLE 51 Global Transitional Cell Carcinoma Segment Market Share, By Region 2012-2016 67
TABLE 52 Global Transitional Cell Carcinoma Segment Market Share, By Region 2017-2022 67
TABLE 53 Global Transitional Cell Carcinoma Segment Y-o-Y, By Region 2015-2022 67
TABLE 54 Global Wilms Tumor Segment Value (US$ Mn), By Region 2012-2016 68
TABLE 55 Global Wilms Tumor Segment Value (US$ Mn), By Region 2017-2022 69
TABLE 56 Global Wilms Tumor Segment Market Share, By Region 2012-2016 70
TABLE 57 Global Wilms Tumor Segment Market Share, By Region 2017-2022 70
TABLE 58 Global Wilms Tumor Segment Y-o-Y, By Region 2015-2022 70
TABLE 59 Global Kidney Lymphoma Segment Value (US$ Mn), By Region 2012-2016 71
TABLE 60 Global Kidney Lymphoma Segment Value (US$ Mn), By Region 2017-2022 72
TABLE 61 Global Kidney Lymphoma Segment Market Share, By Region 2012-2016 73
TABLE 62 Global Kidney Lymphoma Segment Market Share, By Region 2017-2022 73
TABLE 63 Global Kidney Lymphoma Segment Y-o-Y, By Region 2015-2022 73
TABLE 64 Global Kidney Sarcoma Segment Value (US$ Mn), By Region 2012-2016 74
TABLE 65 Global Kidney Sarcoma Segment Value (US$ Mn), By Region 2017-2022 75
TABLE 66 Global Kidney Sarcoma Segment Market Share, By Region 2012-2016 76
TABLE 67 Global Kidney Sarcoma Segment Market Share, By Region 2017-2022 76
TABLE 68 Global Kidney Sarcoma Segment Y-o-Y, By Region 2015-2022 76
TABLE 69 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 78
TABLE 70 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 78
TABLE 71 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 80
TABLE 72 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 80
TABLE 73 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 82
TABLE 74 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 82
TABLE 75 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 84
TABLE 76 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 84
TABLE 77 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 86
TABLE 78 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 86
TABLE 79 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 88
TABLE 80 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 88
TABLE 81 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 90
TABLE 82 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 90
TABLE 83 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 91
TABLE 84 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 92
TABLE 85 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 93
TABLE 86 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 94
TABLE 87 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 95
TABLE 88 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 95
TABLE 89 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 97
TABLE 90 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 97
TABLE 91 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 98
TABLE 92 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 99
TABLE 93 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 100
TABLE 94 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 101
TABLE 95 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 102
TABLE 96 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 102
TABLE 97 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 104
TABLE 98 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 104
TABLE 99 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 106
TABLE 100 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 106
TABLE 101 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 108
TABLE 102 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 108
TABLE 103 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 109
TABLE 104 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 110
TABLE 105 US Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 112
TABLE 106 US Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 112
TABLE 107 US Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 113
TABLE 108 US Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 113
TABLE 109 US Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 114
TABLE 110 US Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 114
TABLE 111 Canada Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 115
TABLE 112 Canada Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 115
TABLE 113 Canada Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 116
TABLE 114 Canada Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 116
TABLE 115 Canada Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 117
TABLE 116 Canada Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 117
TABLE 117 Brazil Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 118
TABLE 118 Brazil Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 118
TABLE 119 Brazil Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 119
TABLE 120 Brazil Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 119
TABLE 121 Brazil Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 120
TABLE 122 Brazil Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 120
TABLE 123 Mexico Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 121
TABLE 124 Mexico Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 121
TABLE 125 Mexico Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 122
TABLE 126 Mexico Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 122
TABLE 127 Mexico Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 123
TABLE 128 Mexico Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 123
TABLE 129 Argentina Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 124
TABLE 130 Argentina Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 124
TABLE 131 Argentina Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 125
TABLE 132 Argentina Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 125
TABLE 133 Argentina Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 126
TABLE 134 Argentina Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 126
TABLE 135 Germany Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 127
TABLE 136 Germany Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 127
TABLE 137 Germany Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 128
TABLE 138 Germany Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 128
TABLE 139 Germany Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 129
TABLE 140 Germany Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 129
TABLE 141 UK Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 130
TABLE 142 UK Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 130
TABLE 143 UK Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 131
TABLE 144 UK Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 131
TABLE 145 UK Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 132
TABLE 146 UK Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 132
TABLE 147 France Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 133
TABLE 148 France Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 133
TABLE 149 France Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 134
TABLE 150 France Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 134
TABLE 151 France Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 135
TABLE 152 France Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 135
TABLE 153 Spain Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 136
TABLE 154 Spain Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 136
TABLE 155 Spain Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 137
TABLE 156 Spain Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 137
TABLE 157 Spain Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 138
TABLE 158 Spain Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 138
TABLE 159 Italy Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 139
TABLE 160 Italy Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 139
TABLE 161 Italy Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 140
TABLE 162 Italy Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 140
TABLE 163 Italy Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 141
TABLE 164 Italy Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 141
TABLE 165 Nordic Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 142
TABLE 166 Nordic Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 142
TABLE 167 Nordic Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 143
TABLE 168 Nordic Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 143
TABLE 169 Nordic Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 144
TABLE 170 Nordic Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 144
TABLE 171 Japan  Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 145
TABLE 172 Japan  Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 145
TABLE 173 Japan  Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 146
TABLE 174 Japan  Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 146
TABLE 175 Japan  Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 147
TABLE 176 Japan  Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 147
TABLE 177 China Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 148
TABLE 178 China Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 148
TABLE 179 China Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 149
TABLE 180 China Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 149
TABLE 181 China Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 150
TABLE 182 China Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 150
TABLE 183 India Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 151
TABLE 184 India Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 151
TABLE 185 India Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 152
TABLE 186 India Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 152
TABLE 187 India Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 153
TABLE 188 India Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 153
TABLE 189 Malaysia Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 154
TABLE 190 Malaysia Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 154
TABLE 191 Malaysia Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 155
TABLE 192 Malaysia Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 155
TABLE 193 Malaysia Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 156
TABLE 194 Malaysia Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 156
TABLE 195 Thailand Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 157
TABLE 196 Thailand Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 157
TABLE 197 Thailand Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 158
TABLE 198 Thailand Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 158
TABLE 199 Thailand Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 159
TABLE 200 Thailand Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 159
TABLE 201 Singapore Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 160
TABLE 202 Singapore Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 160
TABLE 203 Singapore Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 161
TABLE 204 Singapore Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 161
TABLE 205 Singapore Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 162
TABLE 206 Singapore Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 162
TABLE 207 Australia Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 163
TABLE 208 Australia Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 163
TABLE 209 Australia Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 164
TABLE 210 Australia Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 164
TABLE 211 Australia Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 165
TABLE 212 Australia Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 165
TABLE 213 GCC Countries Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 166
TABLE 214 GCC Countries Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 166
TABLE 215 GCC Countries Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 167
TABLE 216 GCC Countries Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 167
TABLE 217 GCC Countries Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 168
TABLE 218 GCC Countries Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 168
TABLE 219 South Africa Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 169
TABLE 220 South Africa Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 169
TABLE 221 South Africa Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 170
TABLE 222 South Africa Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 170
TABLE 223 South Africa Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 171
TABLE 224 South Africa Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 171
TABLE 225 Nigeria Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 172
TABLE 226 Nigeria Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 172
TABLE 227 Nigeria Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 173
TABLE 228 Nigeria Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 173
TABLE 229 Nigeria Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 174
TABLE 230 Nigeria Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 174
TABLE 231 Israel Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 175
TABLE 232 Israel Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 175
TABLE 233 Israel Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 176
TABLE 234 Israel Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 176
TABLE 235 Israel Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 177
TABLE 236 Israel Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 177

FIG. 1 Global Kidney Cancer Diagnostics Market Value (US$ Mn), 2012-2016 19
FIG. 2 Global Kidney Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2022 19
FIG. 3 Global Kidney Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 21
FIG. 4 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2012-2016 24
FIG. 5 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2017-2022 25
FIG. 6 Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2015-2022 27
FIG. 7 Global Urine Analysis Segment Market Value (US$ Mn) By Region, 2012-2016 27
FIG. 8 Global Urine Analysis Segment Market Value (US$ Mn) By Region, 2017-2022 28
FIG. 9 Global Urine Analysis Segment Y-o-Y Growth Rate, By Region, 2015-2022 30
FIG. 10 Global Complete Blood Count Segment Market Value (US$ Mn) By Region, 2012-2016 30
FIG. 11 Global Complete Blood Count Segment Market Value (US$ Mn) By Region, 2017-2022 31
FIG. 12 Global Complete Blood Count Segment Y-o-Y Growth Rate, By Region, 2015-2022 33
FIG. 13 Global Blood Chemistry Test Segment Market Value (US$ Mn) By Region, 2012-2016 33
FIG. 14 Global Blood Chemistry Test Segment Market Value (US$ Mn) By Region, 2017-2022 34
FIG. 15 Global Blood Chemistry Test Segment Y-o-Y Growth Rate, By Region, 2015-2022 36
FIG. 16 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2012-2016 37
FIG. 17 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2022 38
FIG. 18 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2022 40
FIG. 19 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016 40
FIG. 20 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022 41
FIG. 21 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022 43
FIG. 22 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016 43
FIG. 23 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022 44
FIG. 24 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022 46
FIG. 25 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 46
FIG. 26 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 47
FIG. 27 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 49
FIG. 28 Global Renal Cell Carcinoma Segment Market Value (US$ Mn) By Region, 2012-2016 50
FIG. 29 Global Renal Cell Carcinoma Segment Market Value (US$ Mn) By Region, 2017-2022 51
FIG. 30 Global Renal Cell Carcinoma Segment Y-o-Y Growth Rate, By Region, 2015-2022 53
FIG. 31 Global Transitional Cell Carcinoma Segment Market Value (US$ Mn) By Region, 2012-2016 53
FIG. 32 Global Transitional Cell Carcinoma Segment Market Value (US$ Mn) By Region, 2017-2022 54
FIG. 33 Global Transitional Cell Carcinoma Segment Y-o-Y Growth Rate, By Region, 2015-2022 56
FIG. 34 Global Wilms Tumor Segment Market Value (US$ Mn) By Region, 2012-2016 56
FIG. 35 Global Wilms Tumor Segment Market Value (US$ Mn) By Region, 2017-2022 57
FIG. 36 Global Wilms Tumor Segment Y-o-Y Growth Rate, By Region, 2015-2022 59
FIG. 37 Global Kidney Lymphoma Segment Market Value (US$ Mn) By Region, 2012-2016 59
FIG. 38 Global Kidney Lymphoma Segment Market Value (US$ Mn) By Region, 2017-2022 60
FIG. 39 Global Kidney Lymphoma Segment Y-o-Y Growth Rate, By Region, 2015-2022 62
FIG. 40 Global Kidney Sarcoma Segment Market Value (US$ Mn) By Region, 2012-2016 62
FIG. 41 Global Kidney Sarcoma Segment Market Value (US$ Mn) By Region, 2017-2022 63
FIG. 42 Global Kidney Sarcoma Segment Y-o-Y Growth Rate, By Region, 2015-2022 65
FIG. 43 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 66
FIG. 44 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 67
FIG. 45 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 68
FIG. 46 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 69
FIG. 47 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 70
FIG. 48 North America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 71
FIG. 49 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 72
FIG. 50 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 73
FIG. 51 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 74
FIG. 52 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 75
FIG. 53 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 76
FIG. 54 Latin America Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 77
FIG. 55 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 78
FIG. 56 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 79
FIG. 57 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 80
FIG. 58 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 80
FIG. 59 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 81
FIG. 60 Europe Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 82
FIG. 61 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 83
FIG. 62 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 84
FIG. 63 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 85
FIG. 64 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 86
FIG. 65 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 87
FIG. 66 Japan Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 87
FIG. 67 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 88
FIG. 68 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 89
FIG. 69 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 90
FIG. 70 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 91
FIG. 71 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 92
FIG. 72 APEJ Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 93
FIG. 73 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 94
FIG. 74 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 95
FIG. 75 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 96
FIG. 76 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 97
FIG. 77 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2012-2016 98
FIG. 78 MEA Kidney Cancer Diagnostics Market Value (US$ Mn), By Indication 2017-2022 98

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development